Demyelination in the central nervous system sometimes presents with large pseudotumoral lesions mimicking brain neoplasm. Whether tumefactive demyelination constitutes a disease variant within the broad spectrum of multiple sclerosis or rather depicts a different entity is still matter of debate. Thus far, no consensus exists about definition and management of tumefactive lesions since the only available evidence comes from small case series and hospital cohort studies. Pseudotumoral plaques may occur as first neurological event or in the course of well-established MS diagnosis making the distinguishing between demyelination and malignancy even more challenging. Extensive diagnostic work-up is mandatory for proper identification of tumefactive demyelinating lesions (TDLs) to avoid unnecessary and potentially harmful interventions. Despite the lack of patognomonic features, several radiological hallmarks of TDLs can be outlined. Unfortunately in most of cases diagnosis is not straightforward and brain biopsy in eventually required. The aim of this paper is to review clinical findings, diagnostic procedures and treatment of this challenging pathological condition.

Tumefactive demyelinating lesions: Spectrum of disease, diagnosis and treatment

TOTARO, Rocco;DI CARMINE, CATERINA;MARINI, Carmine;CAROLEI, ANTONIO
2016-01-01

Abstract

Demyelination in the central nervous system sometimes presents with large pseudotumoral lesions mimicking brain neoplasm. Whether tumefactive demyelination constitutes a disease variant within the broad spectrum of multiple sclerosis or rather depicts a different entity is still matter of debate. Thus far, no consensus exists about definition and management of tumefactive lesions since the only available evidence comes from small case series and hospital cohort studies. Pseudotumoral plaques may occur as first neurological event or in the course of well-established MS diagnosis making the distinguishing between demyelination and malignancy even more challenging. Extensive diagnostic work-up is mandatory for proper identification of tumefactive demyelinating lesions (TDLs) to avoid unnecessary and potentially harmful interventions. Despite the lack of patognomonic features, several radiological hallmarks of TDLs can be outlined. Unfortunately in most of cases diagnosis is not straightforward and brain biopsy in eventually required. The aim of this paper is to review clinical findings, diagnostic procedures and treatment of this challenging pathological condition.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11697/111777
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 8
  • ???jsp.display-item.citation.isi??? ND
social impact